Tag: DIOV
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy
Seniors With RSV-Linked Hospitalization Have Increased Cardiovascular Outcomes
Patients hospitalized with RSV have greater risk for subsequent heart failure events compared with patients with influenza, UTI, fracture
Increased Risk for CVD Seen for Women With Premenstrual Disorders
Risk particularly pronounced for PMDs diagnosed before 25 years of age and those with comorbid perinatal depression
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
Increased cardiovascular risk over five years also seen in association with delayed diagnosis
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
Consistently and increasingly active individuals have lower risks for all-cause, CVD mortality
Almost 15 Percent of U.S. Seniors Use Aspirin for Primary Prevention
22.7 percent of primary prevention aspirin users started aspirin without a physician's recommendation
Adiposity-Linked Breast Cancer Risk Higher for Women With CVD
BMI was more strongly associated with breast cancer risk in women with versus without cardiovascular disease
Low-Fiber Diet With High Red Meat Linked to High-Risk Coronary Plaque Features
Lowest tertile of dietary index associated with high-risk plaque features, with waist circumference, triglycerides, hypertension as possible mediators
Mild Obstructive Sleep Apnea More Common in Female Athletes Than Expected
Mild OSA present in 25 percent of female collegiate athletes in study
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
Incidence rates of composite of death, MI, stroke were lower, but not significantly so, for patients treated with semaglutide
